CT MPJE key terms

Connecticut statute (General Statutes Chapter 400j) that establishes the Commission of Pharmacy, licensing of pharmacists, pharmacies, and technicians, and the legal standards for prescription dispensing, counseling, and discipline in the state.

Credential issued by the Connecticut Commission of Pharmacy that authorizes an individual who has met education, examination, and internship requirements to practice pharmacy, including dispensing and counseling, within the state.

Connecticut registration permitting a technician to assist a pharmacist with dispensing tasks under supervision. Technicians cannot perform final verification, counsel patients, or exercise independent professional judgment reserved to licensed pharmacists.

Commission-issued permit authorizing a specific physical location to engage in pharmacy practice. It is tied to the premises, the designated pharmacist-in-charge, and compliance with facility, security, and recordkeeping standards.

A written agreement allowing a pharmacist, under defined conditions, to initiate, modify, or monitor drug therapy in cooperation with a prescriber; Connecticut law specifies the settings, patient criteria, and documentation required.

A drug required by federal or state law to be dispensed only on prescription because it is not safe for unsupervised self-use; its label carries the federal legend statement.

A lawful instruction from an authorized prescriber to dispense a specific drug for a specific patient, which may be written, electronic, or oral and must contain the elements required by Connecticut regulation.

The process of evaluating a prescription, preparing and labeling the drug, and transferring it to the patient or caregiver, including the counseling and recordkeeping that accompany that transfer.

Required container information, including pharmacy identity, prescription number, patient and prescriber names, drug name and strength, directions, quantity, date, refills, and any state or federal warnings mandated by law.

An additional dispensing of a prescription without a new prescriber authorization, permitted only within the refills authorized on the original order and before its expiration date.

Movement of prescription dispensing information between pharmacies so the receiving pharmacy may dispense remaining refills; both pharmacies must document the transfer according to state and federal rules.

Dispensing a therapeutically equivalent, lower-cost product in place of the prescribed brand, permitted unless the prescriber indicates that substitution is prohibited, with notification requirements to the patient.

A limited supply dispensed when a prescription's refills are exhausted or expired and the prescriber cannot be reached, subject to Connecticut limits on quantity, drug type, and documentation.

A prescriber-issued protocol allowing pharmacists to dispense naloxone to persons at risk of opioid overdose, or to their family and caregivers, without an individual prescription for that person.

The five federal classifications (I through V) that rank substances by abuse potential and accepted medical use; a drug's schedule determines prescribing, refill, recordkeeping, and security requirements.

Federal registration number required for a pharmacy or practitioner to handle controlled substances. Connecticut also requires a corresponding state controlled substance registration before ordering, storing, or dispensing these drugs.

Statewide electronic database receiving dispensing data for controlled substances and other monitored drugs; pharmacists must report dispensing as required and should review patient history before dispensing opioids or other listed drugs.

A pharmacist's duty to resolve red flags suggesting misuse, diversion, or forgery before dispensing a controlled substance, and to refuse dispensing when the prescription's legitimacy cannot be established.

A complete, dated count of all controlled substances on hand, required at least every two years after initial registration, kept with records and signed by the person taking the inventory.

The order form, paper or electronic through the Controlled Substance Ordering System, used to transfer Schedule I and II drugs between registrants; each order must be completed accurately and retained as a record.

Direct communication with the patient or caregiver about the drug, its use, side effects, and storage, offered by the pharmacist at dispensing; it may be declined and the refusal documented.

A structured review of a prescription against the patient's profile for interactions, duplications, dosing problems, and appropriate use, performed prospectively and, in some settings, retrospectively.

A patient-centered service in which a pharmacist reviews all medications, identifies problems, and develops a plan with the patient and prescribers, typically for patients with multiple chronic conditions.

Harm experienced by a patient related to a medication, including adverse reactions, errors, and near misses; serious events must be documented and may require reporting through the pharmacy's quality program.

An ongoing, documented pharmacy program that tracks dispensing errors and near misses, analyzes causes, and implements changes to prevent recurrence, with records available for inspection.

United States Pharmacopeia standard for nonsterile compounding that addresses personnel training, facilities, equipment, calculations, and beyond-use dating for preparations such as creams, capsules, and oral liquids.

United States Pharmacopeia standard for sterile compounding, covering cleanroom classifications, environmental monitoring, aseptic technique, personnel qualification, and assignment of beyond-use dates for sterile preparations.

United States Pharmacopeia standard for handling hazardous drugs, requiring containment engineering controls, personal protective equipment, deactivation procedures, and documented risk assessments wherever these drugs are received, prepared, or dispensed.

The detailed written procedure for preparing a compounded preparation, including ingredients, quantities, equipment, steps, and quality checks, from which the individual compounding record is generated.

The date after which a compounded preparation must not be used; assigned from stability information, USP limits, water content, storage conditions, and the container in which it is packaged.

A facility registered with FDA that compounds sterile drugs in large quantities without patient-specific prescriptions and must comply with current good manufacturing practice and reporting requirements.

The minimum time pharmacy records must be kept and made available for inspection; federally, controlled substance records require at least two years, while Connecticut rules set separate periods for prescriptions and other records.

A pharmacy operating within a hospital or similar licensed facility, serving inpatients under a permit that allows distribution through floor stock, unit dose, and facility-specific policies.

A drug delivery system in which each dose is packaged and labeled for a single patient administration, improving accuracy and control compared with bulk or floor stock supply.

Medications stored in patient care areas for administration by nursing or other authorized staff rather than dispensed patient-specifically; the pharmacy remains responsible for selection, control, and accountability.

A pharmacy serving residents of nursing facilities and similar settings, providing specialized packaging, delivery, and consultation services, and operating under state licensure and consultant pharmacist requirements.

Federal statute governing drug approval, manufacture, labeling, and marketing, and the basis for prescription-only status, adequate directions for use, and FDA enforcement against adulterated or misbranded products.

Federal law creating a chain of custody for prescription drugs in the supply chain through transaction information, product tracing, verification, and licensing checks on trading partners, including response to suspect or illegitimate product.

A risk evaluation and mitigation strategy is an FDA-required plan that may include medication guides, training, restricted distribution, or patient monitoring to ensure a drug's benefits outweigh its risks.

Federal privacy and security rules protecting identifiable health information, including prescriptions and counseling records, while allowing disclosures for treatment, payment, and specified public health purposes.